Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β 1 integrin

International Journal of Oncology

Volumn 39, Issue 6, 2011, Pages 1593-1600

  Wagner, Britta Janina ^a,c   Stefan, L O B ^a   Lindau, Dennis ^a   Hörzer, Helen ^a,b   Gückel, Brigitte ^b   Klein, Gerd ^b   Glatzle, Jörg ^a   Rammensee, Hans Georg ^a   Brücher, Björn Lucas Dietrich Maria ^a   Königsrainer, Alfred ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Krankenhaus Maria Hilf   (Germany)

Author keywords

Adhesion molecules; Colorectal cancer cells; Ovarian cancer cells; Peritoneal carcinomatosis; Simvastatin

Indexed keywords

BETA1 INTEGRIN; FLUORESCENT DYE; INTERCELLULAR ADHESION MOLECULE 1; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CARCINOMATOUS PERITONITIS; CELL ADHESION; CELL ISOLATION; CELL LINE; CELL STRAIN HT29; DOWN REGULATION; GREATER OMENTUM; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OVARY CANCER; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION; HT29 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; OVARIAN NEOPLASMS; PERITONEUM; PROTEIN BINDING; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 80054825036     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1167     Document Type: Article

References (44)

1. Sugarbaker PH: A perspective on clinical research strategies in carcinoma of the large bowel. World J Surg 15: 609-616, 1991.
2. Bell DA, Longacre TA, Prat J, et al.: Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 35: 934-948, 2004. (Pubitemid 39037177)
3. Agarwal R and Kaye SB: Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3: 502-516, 2003. (Pubitemid 37328838)
4. Daly MB and Ozols RF: Symptoms of ovarian cancer - where to set the bar? JAMA 291: 2755-2756, 2004. (Pubitemid 38725426)
5. Ozols RF: Treatment goals in ovarian cancer. Int J Gynecol Cancer 15: 3-11, 2005.
6. Koppe MJ, Boerman OC, Oyen WJ and Bleichrodt RP: Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243: 212-222, 2006. (Pubitemid 43185440)
7. Esquivel J, Sticca R, Sugarbaker P, et al.: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14: 128-133, 2007. (Pubitemid 44954279)
8. Verwaal VJ, Boot H, Aleman BM, van Tinteren H and Zoetmulder FA: Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol 11: 375-379, 2004. (Pubitemid 40486746)
9. Kenny HA, Krausz T, Yamada SD and Lengyel E: Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer 121: 1463-1472, 2007. (Pubitemid 47328704)
10. Oosterling SJ, van der Bij GJ, Bogels M, et al.: Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 247: 85-94, 2008.
11. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL and Jeekel J: Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328: 1372-1376, 1993. (Pubitemid 23131389)
12. Kanellos I, Demetriades H, Zintzaras E, Mandrali A, Mantzoros I and Betsis D: Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum 46: 535-539, 2003. (Pubitemid 36428052)
13. Sugarbaker PH: Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 37: 115-122, 1994.
14. Yamamoto S, Akasu T, Fujita S and Moriya Y: Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol 33: 33-37, 2003. (Pubitemid 43102878)
15. Jonjić N, Peri G, Bernasconi S, et al.: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176: 1165-1174, 1992.
16. ten Raa RS, van Grevenstein HM, ten Kate M, et al.: The influence of reactive oxygen species on the adhesion of pancreatic carcinoma cells to the peritoneum. Cell Adh Migr 1: 77-83, 2007.
17. Slack-Davis JK, Atkins KA, Harrer C, Hershey ED and Conaway M: Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 69: 1469-1476, 2009.
18. Lessan K, Aguiar DJ, Oegema T, Siebenson L and Skubitz AP: CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154: 1525-1537, 1999. (Pubitemid 29226447)
19. Alkhamesi NA, Ziprin P, Pfistermuller K, Peck DH and Darzi AW: ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metastasis 22: 449-459, 2005. (Pubitemid 41750697)
20. Dianzani C, Brucato L, Gallicchio M, Rosa AC, Collino M and Fantozzi R: Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br J Pharmacol 153: 1153-1161, 2008. (Pubitemid 351415495)
21. Moorman PG and Hamilton RJ: Statins and cancer risk: what do we know and where do we go from here? Epidemiology 18: 194-196, 2007.
22. Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ and Guchelaar HJ: The risk of cancer in users of statins. J Clin Oncol 22: 2388-2394, 2004. (Pubitemid 41115396)
23. Sassano A and Platanias LC: Statins in tumor suppression. Cancer Lett 260: 11-19, 2008.
24. Landsberger M, Wolff B, Jantzen F, et al.: Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells. Atherosclerosis 190: 43-52, 2007. (Pubitemid 44908320)
25. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B and Naruszewicz M: Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells. Life Sci 75: 1287-1302, 2004. (Pubitemid 38845028)
26. Takeda I, Maruya S, Shirasaki T, et al.: Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci 98: 890-899, 2007. (Pubitemid 46691828)
27. Stylianou E, Jenner LA, Davies M, Coles GA and Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37: 1563-1570, 1990. (Pubitemid 20198041)
28. Kayser S, Watermann I, Rentzsch C, Weinschenk T, Wallwiener D and Gückel B: Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition? J Cancer Res Clin Oncol 129: 397-409, 2003. (Pubitemid 36995139)
29. Klein G, Muller CA, Tillet E, Chu ML and Timpl R: Collagen type VI in the human bone marrow microenvironment: a strong cytoadhesive component. Blood 86: 1740-1748, 1995.
30. Van Grevenstein WM, Hofland LJ, Jeekel J and van Eijck CH: The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers. Pancreas 32: 396-402, 2006. (Pubitemid 43772196)
31. Tan DS, Agarwal R and Kaye SB: Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 7: 925-934, 2006. (Pubitemid 44615952)
32. Van Grevenstein WM, Hofland LJ, van Rossen ME, van Koetsveld PM, Jeekel J and van Eijck CH: Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci 52: 2775-2783, 2007. (Pubitemid 47373923)
33. ten Kate M, Hofland LJ, van Grevenstein WM, van Koetsveld PV, Jeekel J and van Eijck CH: Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium. Int J Cancer 112: 943-950, 2004. (Pubitemid 39506999)
34. Wang E, Ngalame Y, Panelli MC, et al.: Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer. Clin Cancer Res 11: 113-122, 2005.
35. Han Z and Wyche JH: Lovastatin induces apoptosis in a metastatic ovarian tumour cell line. Cell Death Differ 3: 223-228, 1996. (Pubitemid 26167152)
36. Liu H, Liang SL, Kumar S, Weyman CM, Liu W and Zhou A: Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemother Pharmacol 63: 997-1005, 2009.
37. Kato S, Smalley S, Sadarangani A, et al.: Lipophilic but not hydrophilic statins selectively induce cell death in gynecological cancers expressing high levels of HMGCoA reductase. J Cell Mol Med 14: 1180-1193, 2010.
38. Van Grevenstein WM, Aalbers AG, ten Raa S, et al.: Surgeryderived reactive oxygen species produced by polymorphonuclear leukocytes promote tumor recurrence: studies in an in vitro model. J Surg Res 140: 115-120, 2007. (Pubitemid 46669542)
39. Königsrainer I, Zieker D, Beckert S, et al.: Local peritonectomy highly attracts free floating intraperitoneal colorectal tumour cells in a rat model. Cell Physiol Biochem 23: 371-378, 2009.
40. Ziprin P, Ridgway PF, Pfistermuller KL, Peck DH and Darzi AW: ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 10: 141-154, 2003. (Pubitemid 38054748)
41. Elmore RG, Ioffe Y, Scoles DR, Karlan BY and Li AJ: Impact of statin therapy on survival in epithelial ovarian cancer. Gynecol Oncol 111: 102-105, 2008.
42. Yu O, Boudreau DM, Buist DS and Miglioretti DL: Statin use and female reproductive organ cancer risk in a large population-based setting. Cancer Causes Control 20: 609-616, 2009.
43. Poynter JN, Gruber SB, Higgins PD, et al.: Statins and the risk of colorectal cancer. N Engl J Med 352: 2184-2192, 2005. (Pubitemid 40727085)
44. Kuoppala J, Lamminpaa A and Pukkala E: Statins and cancer: a systematic review and meta-analysis. Eur J Cancer 44: 2122-2132, 2008.